These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 15278000)
1. Bone marrow transplantation in the course of hematological malignancies--follow-up study in blood serum by 31P MRS. Kuliszkiewicz-Janus M; Baczyński S; Jurczyk A Med Sci Monit; 2004 Aug; 10(8):CR485-92. PubMed ID: 15278000 [TBL] [Abstract][Full Text] [Related]
2. Application of 31P NMR spectroscopy in clinical analysis of changes of serum phospholipids in leukemia, lymphoma and some other non-haematological cancers. Kuliszkiewicz-Janus M; Janus W; Baczyński S Anticancer Res; 1996; 16(3B):1587-94. PubMed ID: 8694531 [TBL] [Abstract][Full Text] [Related]
3. Treatment-induced changes in 31P-MRS (magnetic resonance spectroscopy) spectra of sera from patients with acute leukemia. Kuliszkiewicz-Janus M; Baczyński S Biochim Biophys Acta; 1997 Feb; 1360(1):71-83. PubMed ID: 9061042 [TBL] [Abstract][Full Text] [Related]
4. 31P MRS analysis of the phospholipid composition of normal human peripheral blood mononuclear cells (PBMC). Kuliszkiewicz-Janus M; Tuz MA; Baczyński S; Prajs I; Jaźwiec B Cell Mol Biol Lett; 2005; 10(3):373-82. PubMed ID: 16217549 [TBL] [Abstract][Full Text] [Related]
5. Application of 31P MRS to the analysis of phospholipid changes in plasma of patients with acute leukemia. Kuliszkiewicz-Janus M; Tuz MA; Baczyński S Biochim Biophys Acta; 2005 Oct; 1737(1):11-5. PubMed ID: 16213190 [TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-associated changes in 31P MRS spectra of sera from patients with multiple myeloma. Kuliszkiewicz-Janus M; Baczyński S NMR Biomed; 1995 May; 8(3):127-32. PubMed ID: 8580000 [TBL] [Abstract][Full Text] [Related]
7. [Significance of dynamic detection of WT1 expression on monitoring minimal residual disease in leukemia patients following allogeneic bone marrow transplantation]. Gu WY; Chen ZX; Hu SY; Zhu J; Wang ZL; Yan F; Wang W; Cen JN; Shen HL; Qian J Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):444-7. PubMed ID: 15854547 [TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of secondary malignancies in adults after allogeneic bone marrow transplantation. Hasegawa W; Pond GR; Rifkind JT; Messner HA; Lau A; Daly AS; Kiss TL; Kotchetkova N; Galal A; Lipton JH Bone Marrow Transplant; 2005 Jan; 35(1):51-5. PubMed ID: 15516939 [TBL] [Abstract][Full Text] [Related]
9. Lung function, pulmonary complications, and mortality after allogeneic blood and marrow transplantation in children. Kaya Z; Weiner DJ; Yilmaz D; Rowan J; Goyal RK Biol Blood Marrow Transplant; 2009 Jul; 15(7):817-26. PubMed ID: 19539213 [TBL] [Abstract][Full Text] [Related]
10. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience. Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465 [TBL] [Abstract][Full Text] [Related]
11. Successful renal transplantation following prior bone marrow transplantation in pediatric patients. Thomas SE; Hutchinson RJ; DebRoy M; Magee JC Pediatr Transplant; 2004 Oct; 8(5):507-12. PubMed ID: 15367289 [TBL] [Abstract][Full Text] [Related]
12. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors. Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615 [TBL] [Abstract][Full Text] [Related]
13. Unrelated bone marrow transplantation for high-risk anaplastic large cell lymphoma in pediatric patients: a single center case series. Cesaro S; Pillon M; Visintin G; Putti MC; Gazzola MV; D'Amore E; Scarzello G; Zanesco L; Messina C; Rosolen A Eur J Haematol; 2005 Jul; 75(1):22-6. PubMed ID: 15946306 [TBL] [Abstract][Full Text] [Related]
14. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
15. Long-term renal function following bone marrow transplantation. Grönroos MH; Bolme P; Winiarski J; Berg UB Bone Marrow Transplant; 2007 Jun; 39(11):717-23. PubMed ID: 17401393 [TBL] [Abstract][Full Text] [Related]
16. Normal-looking skin in oncohaematological patients after allogenic bone marrow transplantation is not normal. Vassallo C; Brazzelli V; Alessandrino PE; Varettoni M; Ardigò M; Lazzarino M; Borroni G Br J Dermatol; 2004 Sep; 151(3):579-86. PubMed ID: 15377343 [TBL] [Abstract][Full Text] [Related]
17. Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up. Gaziev J; Sodani P; Polchi P; Andreani M; Lucarelli G Ann N Y Acad Sci; 2005; 1054():196-205. PubMed ID: 16339666 [TBL] [Abstract][Full Text] [Related]
18. Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation. Casorati G; Locatelli F; Pagani S; Garavaglia C; Montini E; Lisini D; Turin I; Rossi F; Dellabona P; Maccario R; Montagna D Exp Hematol; 2005 Feb; 33(2):212-8. PubMed ID: 15676215 [TBL] [Abstract][Full Text] [Related]
19. Magic angle spinning NMR and 1H-31P heteronuclear statistical total correlation spectroscopy of intact human gut biopsies. Wang Y; Cloarec O; Tang H; Lindon JC; Holmes E; Kochhar S; Nicholson JK Anal Chem; 2008 Feb; 80(4):1058-66. PubMed ID: 18205334 [TBL] [Abstract][Full Text] [Related]
20. Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up. Rohatiner AZ; Nadler L; Davies AJ; Apostolidis J; Neuberg D; Matthews J; Gribben JG; Mauch PM; Lister TA; Freedman AS J Clin Oncol; 2007 Jun; 25(18):2554-9. PubMed ID: 17515573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]